Warner-Lambert v Actavis ‘disappointing’ for innovators: lawyers
15-11-2018
UK Supreme Court issues Warner-Lambert v Actavis ruling
14-11-2018
UK Supreme Court grants BIA intervention request in plausibility case
18-01-2018
tupungato / iStockphoto.com
Infringement and plausibility were the biggest issues on the battleground in the UK Supreme Court’s hearing in a case dealing with second medical use patents, as Claire Phipps-Jones, Katie Cambrook and Rachel Mumby of Bristows report.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Warner Lambert, UK Supreme Court, UK BioIndusry Association, Actavis, Mylan, patent, patent invalidity, plausibility, Bristows
